4//SEC Filing
Griffin Stephen D. 4
Accession 0001171843-25-003729
CIK 0000898437other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:01 PM ET
Size
9.4 KB
Accession
0001171843-25-003729
Insider Transaction Report
Form 4
Griffin Stephen D.
EVP, CFO & COO
Transactions
- Exercise/Conversion
Common Stock
2025-06-03+12,840→ 13,640 total - Tax Payment
Common Stock
2025-06-03$11.59/sh−3,769$43,683→ 9,871 total - Exercise/Conversion
Restricted Stock Unit
2025-06-03+12,840→ 25,680 totalExercise: $0.00→ Common Stock (12,840 underlying)
Footnotes (5)
- [F1]Reflects the first vesting installment of RSUs granted on June 3, 2024.
- [F2]Includes 800 shares acquired on May 14, 2025 under the Anika Therapeutics, Inc. Employee Stock Purchase Plan.
- [F3]Reflects an aggregate of 3,769 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on June 3, 2025.
- [F4]Reflects the closing price of ANIK common stock on June 3, 2025, the trading date on which the vesting of RSUs gave rise to tax withholding obligations.
- [F5]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning June 3, 2025.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001831125
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 5:01 PM ET
- Size
- 9.4 KB